GDF15-GFRAL Axis as Systemic Autophagy-Senescence Integrator

Target: GDF15, GFRAL, NTRK2 Composite Score: 0.653 Price: $0.65 Citation Quality: Pending molecular biology Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
⚠ Missing Evidence⚠ Low Validation Senate Quality Gates →
Quality Report Card click to collapse
B
Composite: 0.653
Top 41% of 984 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
B Mech. Plausibility 15% 0.62 Top 58%
C+ Evidence Strength 15% 0.58 Top 54%
B Novelty 12% 0.65 Top 71%
B+ Feasibility 12% 0.70 Top 33%
B Impact 12% 0.68 Top 55%
B Druggability 10% 0.60 Top 48%
B+ Safety Profile 8% 0.72 Top 24%
B+ Competition 6% 0.70 Top 42%
B Data Availability 5% 0.68 Top 43%
B Reproducibility 5% 0.65 Top 40%
Evidence
3 supporting | 2 opposing
Citation quality: 0%
Debates
1 session B+
Avg quality: 0.78
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

What is the optimal therapeutic window timing for autophagy enhancement versus senolytic intervention?

The sequential therapy hypothesis depends on identifying when autophagy failure transitions to irreversible senescence, but no biomarkers or timing parameters were established. This temporal relationship is critical for the proposed therapeutic approach but remains undefined. Source: Debate session sess_SDA-2026-04-04-gap-senescent-clearance-neuro (Analysis: SDA-2026-04-04-gap-senescent-clearance-neuro)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

p16^INK4a-CCF Axis as Senolytic Timing Biomarker
Score: 0.725 | Target: CDKN2A, CGAS, STING1
p21^Cip1 Phospho-State as Autophagy Responsiveness Predictor
Score: 0.710 | Target: CDKN1A, CDK4, CDK6, ATM, PPP1CA
mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker
Score: 0.685 | Target: MTOR, RPTOR, RPS6KB1, TSC1, TSC2
Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic Windows
Score: 0.614 | Target: TFEB, MAPK14, MAPKAPK2, IL6, CXCL1
Lamin B1 Degradation as Irreversibility Gate
Score: 0.523 | Target: LMNB1, LMNB2, NCOA4, SQSTM1
Nucleolar p21-rRNA Co-Aggregation as Irreversible Senescence Gate
Score: 0.500 | Target: NCL, FBL, AMBRA1, CDKN1A

→ View full analysis & all 7 hypotheses

Description

Mitochondrial dysfunction drives GDF15 secretion as an integrated stress response. GDF15 elevation above 300 pg/mL reflects autophagy-lysosome system failure at the organismal level, shifting the therapeutic window from autophagy enhancement to senolytic intervention. GDF15 acts via GFRAL-TRKB receptor in hindbrain neurons, promoting lysosomal permeabilization and enabling biomarker-based patient stratification.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.62 (15%) Evidence 0.58 (15%) Novelty 0.65 (12%) Feasibility 0.70 (12%) Impact 0.68 (12%) Druggability 0.60 (10%) Safety 0.72 (8%) Competition 0.70 (6%) Data Avail. 0.68 (5%) Reproducible 0.65 (5%) 0.653 composite
5 citations 5 with PMID Validation: 0% 3 supporting / 2 opposing
For (3)
No supporting evidence
No opposing evidence
(2) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
4
1
MECH 4CLIN 1GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
GDF15 is a biomarker of autophagy-lysosome dysfunc…SupportingCLIN----PMID:36650079-
GDF15-GFRAL signaling impairs autophagy in Parkins…SupportingMECH----PMID:38013355-
Serum GDF15 correlates with senescent cell burden …SupportingMECH----PMID:36226782-
GDF15 threshold of 300 pg/mL is empirically derive…OpposingMECH----PMID:N/A-
GFRAL expression is primarily hindbrain-restricted…OpposingMECH----PMID:N/A-
Legacy Card View — expandable citation cards

Supporting Evidence 3

GDF15 is a biomarker of autophagy-lysosome dysfunction in aging
GDF15-GFRAL signaling impairs autophagy in Parkinson's disease models
Serum GDF15 correlates with senescent cell burden in ALS

Opposing Evidence 2

GDF15 threshold of 300 pg/mL is empirically derived and unvalidated prospectively
GFRAL expression is primarily hindbrain-restricted; CNS-wide effects unclear
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-21 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Therapeutic Hypotheses: Autophagy-Senescence Temporal Window in Neurodegeneration

Hypothesis 1: mTORC1 Reactivation as a Divergence Point Marker

Title: Circadian mTORC1 dysregulation marks the transition from autophagy-reversible stress to senescence commitment

Mechanism: Progressive mTORC1 hyperactivation during aging disrupts the autophagy-lysosome flux, leading to p62/SQSTM1 aggregation, DNA damage response (DDR) activation via ATM/ATR, and stabilization of p21^Cip1/Waf1. The nuclear translocation of mTORC1-sensed nutrients creates a feedforward loop where impaired auto

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Autophagy-Senescence Therapeutic Window Hypotheses

Overarching Methodological Concerns

Before examining individual hypotheses, several systemic issues affect the entire framework:

1. Temporal Directionality Problem
All hypotheses assume a unidirectional transition: autophagy failure → senescence commitment. However, this causality may be reversed in some contexts—senescence itself can cause autophagy dysregulation, creating circular causation that complicates biomarker interpretation.

2. Cell-Type Heterogeneity Gap
Evidence citations derive predominant

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Feasibility Assessment: Autophagy-Senescence Temporal Window Hypotheses in Neurodegeneration

Executive Summary

Of the seven proposed hypotheses, five represent tractable research programs with defined validation pathways, while two require substantial reconceptualization. The most viable candidates integrate validated pharmacological mechanisms with emerging biomarkers that can be assessed in human-derived systems. However, all surviving hypotheses face a common bottleneck: the absence of prospective clinical validation linking biomarker states to differential therapeutic response. The

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

No price history recorded yet

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (4)

Paper:36226782
No extracted figures yet
Paper:36650079
No extracted figures yet
Paper:38013355
No extracted figures yet
Paper:N/A
No extracted figures yet

📓 Linked Notebooks (0)

No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

Related Hypotheses

miR-33 Antisense Oligonucleotide Hyper-Lipidation Strategy
Score: 0.741 | molecular biology
p16^INK4a-CCF Axis as Senolytic Timing Biomarker
Score: 0.725 | molecular biology
p21^Cip1 Phospho-State as Autophagy Responsiveness Predictor
Score: 0.710 | molecular biology
mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker
Score: 0.685 | molecular biology
Conserved 5' Terminal Stem-Loop in NORAD Enables ASO-Mediated Restoration of Genomic Stability
Score: 0.647 | molecular biology

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

3D Protein Structure

🧬 GDF15 — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for GDF15 structures...
Querying Protein Data Bank API

Source Analysis

What is the optimal therapeutic window timing for autophagy enhancement versus senolytic intervention?

molecular biology | 2026-04-07 | archived

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)